We provide ISO 17043 accredited External Quality Assessment (EQA) or Proficiency Testing (PT) schemes which are designed to test the whole analytical process of a molecular diagnostics laboratory including the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.
With effect from 18th January 2019, if you use the SNPCheck service, please point your browsers to its NEW web domain address by visiting the link below.
EMQN is separating from its host organisation (Manchester University NHS Foundation Trust) and will be a completely new independent company know as EMQN CIC.
We are currently finalising the set up of EMQN CIC and we will be invoicing for 2019 schemes in October 2019. Invoices will be sent from and paid to EMQN CIC.
2020 scheme invoices will be sent from EMQN CIC in April 2020.
We will supply all company and bank account information for EMQN CIC in October 2019.
EMQN's scheme catalogue for 2020 is now published and available from the EMQN Home Page. If you have an account you can purchase these, please ensure you fully check out your order to complete the purchase. If you do not have an account, please apply through the EMQN website. Your account will be approved in 24 hours and you can then purchase schemes. Please note the purchase deadline for Germline Scheme is 30/11/2019 and the deadline for Molecular Pathology and Technical Schemes is 28/02/2020
Severe Combined Immunodeficiencies (SCIDs),
Microsatellite Instability (MSI) testing.
See the 2020 EQA scheme catalogue for more information.
Membership of EMQN gives your laboratory access to world class resources in genomics to help improve your performance.
Validated genotypes published for 2019 BRCA Ovarian EQA schemes - https://t.co/tQILKcApBr
Interested in testing new NIPT reference materials? EMQN is funding a validation study as part of an Innovate UK pr… https://t.co/XG9f9a4at4
Provisional results from 2019 Molecular Pathology EQA schemes published today. Log in to your EMQN account to acces… https://t.co/UTTHR5jYRD